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INTRODUCTION
Evolution  of  surgical  techniques  in  partial  hepatectomy  has  enabled  the 
procedure to  be performed with operative mortality rate  of less than 5% in high-
volume centers in recent years.1–5 Before the 1980s, hepatic resection was typically 
associated with a mortality rate of greater than 10%.6–9 Better understanding of the 
segmental liver anatomy and refined surgical techniques in controlling hemorrhage 
are the 2 most important factors that have contributed to the improved perioperative 
outcome of hepatectomy.5,10 Another important factor is the better selection of patients 
in terms of liver function reserve and comorbid conditions,  which helps to reduce 
mortality  from liver  failure  and  other  severe  postoperative  complications  such  as 
pneumonia.3,11,12 Finally,  the  concentration  of  hepatic  resection  in  experienced 
hepatobiliary centers is also a critical factor. Recent studies from other countries have 
demonstrated that a high hospital mortality rate of around 10% is still being observed 
in low-volume hospitals, whereas the hospital mortality rate in high-volume centers is 
less than 5%13,14.The improved safety of hepatic resection has led to the broadening of 
the indications of hepatectomy in patients with normal liver.3,4 partial hepatectomy in 
combination with other major procedures is now performed with greater frequency.
Partial hepatectomy is now performed more frequently in good-risk patients 
with conditions associated with normal liver, such as colorectal liver metastasis.15 The 
improved safety of hepatic resection has also led to a more liberal application of the 
procedure in patients with benign tumors.16 With the enhanced safety, some surgeons 
have advocated hepatic resection for some noncolorectal liver metastases even though 
the oncological benefit remains unclear. 17,18 However, the role of hepatic resection in 
patients with chronic liver disease is still considered limited because of the associated 
increase in operative mortality and morbidity, especially when major hepatic resection 
is required. 14,19,20 Advanced age is considered another limiting factor as several recent 
6
studies  have  reported  that  elderly  patients  had  significantly  increased  operative 
morbidity and mortality.4,14,20 It remains to be demonstrated that the role of hepatic 
resection  can  be  extended  to  such  high-risk  patients  with  favorable  perioperative 
outcome. The practice of hepatic resectional surgery thus continues to evolve, but few 
large, contemporary studies have specifically evaluated the impact of these changes.21 
The  present  study  analyzes  consecutive,  unselected  patients  undergoing  hepatic 
resection over the past three years to further define factors associated with morbidity 
and mortality and to evaluate trends in operative and perioperative variables over the 
period of study.
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AIMS AND OBJECTIVES
The current study aims to analyze the trends in perioperative outcome of 40 
consecutive patients with hepatectomy for various benign or malignant hepatobiliary 
diseases in a specialized hepatobiliary center over a period between August 2004 and 
March  2007,  with  a  particular  reference  to  the  prevalence  of  underlying  risk 
conditions such as impaired liver function reserve,  advanced age,  and presence of 
comorbid illnesses. 
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REVIEW OF LITERATURE
Liver  surgery  has  a  recent  history  compared  to  other  branches  of  surgery 
which evolved gradually, achieving technical standardization and worldwide adoption 
many decades earlier. The modern era of liver surgery dates just 50 years, when the 
intra hepatic segmental anatomy was classified. Progress from pioneering to routine 
surgery is  even  more  recent,  corresponding  to  the  advent  of  ultrasonography and 
improvements  in  diagnostic  and  interventional  radiology  over  the  past  30  years. 
Resectional surgery has undoubtedly benefited from the experience gained both in 
anesthesia and perioperative and post operative care of the liver transplant patients.
For the surgeon, the importance of precise knowledge of the hepatic anatomy 
and its variants is perhaps no where more apparent than in hepatic surgery. Detailed 
anatomical studies, particularly works of Glisson, Cantlie, Couinaud, Goldsmith and 
Woodburne have defined the segmental anatomy that is essential for hepatectomies. 
The anatomical  division  between the right  and left  lobes  follows a  line  projected 
through a plane (the principal plane or Cantlie line) running from the medial margin 
of the gallbladder bed to the IVC posteriorly. Each major right and left portion of the 
liver  is  further  subdivided  in  to  sectors  and  segments.  Between  the  sectors,  the 
draining hepatic veins converge posteriorly towards the vena cava and mark the main 
scissura of the liver. Each segment is supplied by a portal triad.
Patient Assessment
Medical  evaluation  is  done  as  for  any  major  upper  abdominal  surgery. 
Pulmonary complications are particularly common after liver resection because of a 
high transverse incision is always accompanied significant incisional discomfort. The 
sympathetic right pleural effusion that is uniformly present after liver resection further 
compromises the respiratory function. Patients with preexisting cardiac conditions are 
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also at an added risk. Patients with parenchymal disease should be specifically assessed 
for  gas  exchange  impairment,  alcoholic  or  nutritional  associated  cardiomyopathy, 
infection,  decompensation  due  to  cirrhosis,  acute  alcoholic  hepatitis  and  renal 
impairment. Advanced chronological age is no longer a contraindication to surgery. 
Assessment of the Liver
Liver resections are increasingly performed as a standard treatment of various 
hepatobiliary  diseases.  However,  there  were  few  contemporary  studies  of  the 
perioperative  outcome of  hepatic  resection.3-5 In  a  study of  747 hepatectomies  by 
Belghiti et al3 demonstrated a operative mortality of 1% in patients with normal liver, 
but the operative mortality rate was 8.7% in cirrhotic patients. Jarnagin et al4 reported 
a  series  of  1803  patients  with  hepatic  resection  and  demonstrated  a  significant 
improvement in the perioperative outcome over the study period, which was attributed 
to the increased use of parenchymal preserving segmental resections and decrease in 
the number of hepatic segments resected. More recently Imamura et al reported zero 
mortality after hepatic resection in a series of 915 patients. The authors emphasized 
the importance of case selection, and they adopted a strict selection in terms of liver 
function reserve.
Assessment of liver function is a critically important tool for selecting patients 
for hepatic surgery. Not only is it important in the assessment of a patient's ability to 
withstand resection, it also has clearly played a role in the selection process that 
surgeons apply to individual patients in tailoring the appropriate extent of resection. 
These decisions are based on the requirement for adequate margins of resection, 
balanced against any underlying hepatic functional impairment that tends to limit the 
safe extent of resection.
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                 In recent years, the assessment of liver function has had an increasingly  
important role, as surgeons attempt to overcome the limits of anatomic constraints and 
the volume of tumor to  increase resection rates.  For it  must not be forgotten that 
surgical resection remains the mainstay of cure for patients with hepatic malignancies, 
and no effort to achieve resection should go unexplored. The importance of assessing 
liver  function  has  been  further  increased  because  the  goal  of  several  aggressive 
preoperative  therapies  designed  to  improve  the  liver  functional  reserve  before 
resection requires some means of assessing whether, in fact, functional reserve has 
been  improved.  Successful  liver  resection  for  primary  or  metastatic  liver  tumors 
involves the surgeon's recognition that hepatic regeneration will occur, and that this 
metabolic  demand is  superimposed on the  necessary homeostatic  functions  of  the 
liver. Postoperative tolerance of resection and the ability to regenerate the missing 
parenchyma  are  markedly  different  among  patients.  The  generally  acknowledged 
equivalency of limited versus major lobar and extended resections has, in a sense, 
been  an  implied  recognition  of  the  limitations  on  resection  imposed  by  such 
conditions as cirrhosis. 
What is hepatic reserve? – the surgeon’s concept over the years, experienced 
hepatobiliary surgeons have developed selection criteria that allow them to avoid or to 
limit liver resection in patients whose ability to tolerate resection appears impaired. In 
part, this decision process has been aided by clinical classification systems such as the 
Child classification scheme and various liver-function tests. Despite these tools, it is 
surprising to  some clinicians  that  liver  failure remains  a  significant  contributor  to 
postoperative  morbidity  and  mortality.  By  the  same  token,  experienced  hepatic 
surgeons have a remarkable ability to match patients to an appropriate operation, thus 
achieving maximal benefit with low risk.
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In Table 1, several series are reviewed in which the overall liver failure rate 
leading to death ranges from 2% to 65% following hepatic resection for hepatocellular 
carcinoma (HCC).  Patients  who have  HCC often  have  underlying  cirrhosis  as  an 
etiologic  factor  for  their  tumors;  thus  liver  failure  as  a  cause  of  postoperative 
mortality is not surprising in this group. What is often more surprising, however, is 
that  liver  failure  is  a  substantial  component  of  mortality  after  liver  resection  for 
colorectal cancer. Table 2 indicates that mortality rates after resection for colorectal 
cancer have a wide range,  with up to 50% of deaths stemming from liver failure. 
Prolonged recovery and even late deaths can also occur for this same reason, further 
indicating the importance of liver reserve in recovery from hepatic surgery.
Table 1
Liver Failure after hepatic resection: hepatocellular carcinoma
No. Patients Deaths Deaths due to liver failure (%)
Kanematsu et al 85 50 4 (limited) 1 (25%)
 2 (lobar) 1 (50%)
Lee et al 86 109 6 3 (50%)
Nagasue et al 54 118 9 5 (55%)
Nagao et al 53 99 19 8 (42%)
Tsao et al 87 322 48 32 (65%)
Arii et al 88 3395 2–25%
Nonami et al 89 262 27 27 (100%)
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Table 2
Liver failure after hepatic resection: colorectal cancer metastases
No. Patients Deaths Deaths due to liver failure (%)
Fortner 95 65 6 3 (50%)
Iwatsuki 96 48 1 0
Ekberg et al 90 81 4 2 (50%)
Nordlinger et al 91 80 4 2 (50%)
Doci et al 92 100 5 0
Doci et al 93 208 5 2 (40%)
Nordlinger et al 94 1568 36 (2.3%) 6 (16%)
What then is hepatic reserve? Moving beyond the financial analogy, hepatic 
reserve is the combined functions of the liver as determined by hepatic parenchyma, 
the reticuloendothelial  system, unique cells  in  the liver  (ie,  Ito cells),  and hepatic 
blood flow, including major arterial, portal venous, hepatic venous; and microvascular 
blood flow in the spaces of Disse. Preservation of parenchymal volume appears to be 
under the complex control of a number of factors derived from the portal  venous 
circulation,  including  insulin  and  hepatocyte  growth  factors  among  others.  The 
functions of the liver are varied and some are quite complex. A simplistic summary of 
liver function includes the synthesis and degradation of glucose and glycogen, fatty 
acid metabolism, and the synthesis of a variety of proteins, as well as detoxification of 
lipid soluble toxins, degradation of bilirubin, and the general degradation of serum 
proteins targeted for routine turnover.
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The  clinical  assessment  of  hepatic  function  has  evolved  from  the  Child 
system, developed to understand the significance of cirrhotic liver injury and portal 
hypertension  as  they related  to  patient  survival  and surgical  outcomes  for  portal-
systemic shunt surgery 48. This system has also been applied to determine mortality 
estimates  for  elective  operations,  and as  a  means to  follow the  clinical  course of 
patients with liver disease, in an effort to recognize changes that require alterations in 
therapeutic strategy.
The original Child system assessed the degree of ascites,  the presence and 
severity of encephalopathy, and the levels of bilirubin and albumin (Table 3)49. Recent 
modifications of the Child assessment have included the Pugh modification, which 
includes the prothrombin time (or international normalized ratio (INR)) and does not 
look at  nutritional status, except indirectly via plasma albumin levels50.  In another 
modification, the Child-Campbell system, a scoring system similar to that of Child-
Pugh (CP) is used—presence and degree of ascites,  encephalopathy, bilirubin, and 
albumin,  and  nutritional  status  are  considered.  By  replacing  the  evaluation  of 
prothrombin time or INR with nutrition assessment, the Child-Campbell score can be 
obtained in locales without the ability to obtain those coagulation tests51. Less widely 
applied  alternatives  to  the  CP and  Child-Campbell  scores  include  the  Apache  III 
scoring system, and ANS, or ascites/nutritional score. The CP score has widest use 
among surgeons. This has been facilitated by its simple scoring system (Table 4 )50, 51.
Table 3
Hepatic function assessment using the Child system and its modifications
Variable Child Pugh Campbell
Ascites X X X
Nutrition X
Encephalopathy X X X
Bilirubin X X X
Albumin X X X
Protime/international normalized ratio (INR) X
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Table 4
Child-Pugh scoring system
a Child-Pugh Class A, 5–6 total points; Child-Pugh Class B, 7–9 total points; Child-
Pugh Class C, 10–15 total points.
Points 1 2 3
Ascites None diuretic controlled Tense
Encephalopathy Absent State I–II State III–IV
Albumin (g/L) >3.5 2.8–3.5 <2.8,
Bilirubin (mg/dL) <2 2–3 >3
PT(sec above control), or <4 4–6 >6
INR <1.7 1.7–2.3 >2.3
How useful are these clinical systems? How is general survival equated with 
the  A,  B,  and  C  stratification  resulting  from  the  Child  classification  and  its 
refinements? What has been the predictive value of these systems? And, particularly, 
how well do these classification schemes predict outcomes in liver resection? Are they 
useful for defining the limits of resection; that is, the limits of hepatic reserve?
In the CP system, a score of 5 to 6 garners a Child A classification. Patients in 
this stratum generally would be presumed to have virtually no risk for mortality from 
liver-related causes during the subsequent year. With increasing debility, scores of 7 to 
9 merit a classification of B, and these cirrhotic patients carry a 20% risk of 1-year 
mortality from liver-related complications of cirrhosis such as variceal bleeding and 
hepatic failure. A CP score of 10 to 15 out of a total score possible score of 15 merits 
a C classification. Such patients bear a 55% 1-year mortality risk, again stemming 
from  complications  of  cirrhosis  such  as  gastrointestinal  bleeding  and  hepatic 
encephalopathy.  Patients  classified  as  B or  C become eligible  for  liver  transplant 
evaluation.
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In the Campbell system (substituting nutritional status for prothrombin time), 
cooperative group data from the Euricterus database demonstrated that only 5% of 
1015 cirrhotics  would merit  classification by Child's  criteria51.  With the Campbell 
modification, 19% could be classified as Child Class A, and 46% could be classified 
as Child Class B. Their data also demonstrated that the Pugh's modified Child score, 
and even the ANS system, also refine the risk estimates for early stage cirrhosis, and 
therefore may be presumed to provide a better prediction of complications or death 
from hepatic failure. One would assume that this would apply to surgical risk, as well.
Unfortunately, the predictive value of the Child score for liver resections has 
been shown to be quite variable. Franco et al52, for example, demonstrated that the 
mortality for a Child Class A patient undergoing liver resection was 3.7%, versus 
16.7% for both Child Class B and C patients, despite the fact that limited resections 
were  employed.  Nagao  et  al  and  Nagasue  et  al  demonstrated  no  differences  in 
mortality  based  on  Child's  stratification53,  54.  Bismuth  et  al,  attempting  to  use  a 
modified  stratification system to predict  the  limits  of  resection  by stage,  reported 
some success, yet noted five deaths in his series, including those of three early-stage 
cirrhotic  patients  who  had  marginal  amounts  of  liver  resected  and  who  by 
preoperative prediction should have survived55.
Most hepatic surgeons have discovered that the CP scoring system provides 
refined  predictions  of  risk  compared  with  the  Child  scheme;  however,  there  is  a 
persisting unreliability of even the CP score with regard to the Child Class A patients 
(CP  score  5–6).  For  this  reason,  hepatic  surgeons  have  pursued  laboratory  and 
imaging measures to bolster their clinical assessments and to provide objective data to 
bolster clinical judgments of patient risk from impaired hepatic reserve. In essence, 
there is a need to identify “good risk” Child-Pugh A patients and “poor risk” Child-
Pugh A patients.
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Laboratory and imaging studies to augment Child-Pugh assessment
To overcome the limitations of the CP score for predicting risk of liver failure 
in patients who are to undergo hepatic surgery, various biochemical tests and imaging 
studies designed to assess some specific aspect of liver function have been employed 
to assist in the assessment. These include a variety of single laboratory tests, clearance 
and tolerance tests,  functional imaging, and volumetric tests  based on radiological 
imaging, some of which are listed in Box 1.
Box 1 Various tests of liver function used to assess hepatic reserve 
Clearance/tolerance tests 
Aminopyrine breath test 
Indocyanine green (ICG) retention (clearance) 
Bromosulpthalein (BSP) retention 
Galactose tolerance 
Bile acid tolerance 
Beta-hydroxy butyrate/acetoacetate
Functional imaging and blood flow: uptake/clearance 
Reticuloendothelium 
Gold 
Sulfur colloid 
Biliary excretion 
Rose Bengal 
Hepatic diacetic acid (HIDA) 
Receptor targeting 
Neogalactosyl albumin (NGA) 
Galactosyl serum albumin (GSA)
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The ideal function test has yet to be invented. The complexity of liver function 
is such that this is no surprise; however, a successful liver function test, to assist with 
preoperative  assessment  of  liver  function  should  be  safe,  reproducible,  and easily 
performed in an outpatient setting. From the busy surgeon's standpoint, the best test is 
one that can be performed by colleagues or ancillary staff with the time and facilities 
to achieve these characteristics. Unfortunately, ease of performance is often linked to 
analyses  intended  to  simplify  the  complex  results  for  ease  of  interpretation.  The 
resulting oversimplification of the analysis may reduce the utility of the tests.
How useful have these tests been in predicting surgical outcome? Clearly the 
tests employed have been employed because of their ease of application. No single 
test appears to account for the variability of clinical resection results, and, as will be 
demonstrated,  at  this  point in  time no existing test  has proven better  than the CP 
system for assessing hepatic functional reserve.
There  is  no  single  laboratory  test  capable  of  providing  this  information. 
Clearance and tolerance tests, however, offer seemingly attractive means to augment 
the CP assessment (see Box 1). Of these, the most widely used is indocyanine green 
(ICG) retention. ICG retention is worth focusing on because of its clear selection as 
the most popular augmentative test used to select patients for resection following CP 
scoring.
Indocyanine green retention
ICG is a tricarbocyanine dye that binds to albumin and alpha-1 lipoproteins. 
Its active transfer into the liver parenchymal cells leads to a rapid disappearance from 
the plasma, and it appears to be solely removed by the liver 56. From the parenchymal 
cell, it is secreted into the bile in much the same way as an earlier function test dye, 
bromsulpthalein57. The surgical community has generally opted for the retention time 
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at 15 minutes as a single test—ICG 15. This can be determined by serum sampling, 
or,  as  described  recently,  the  percent  retention  can  be  determined  by  pulsed 
spectrophotometry, using an optical sensor placed on the finger in a similar fashion to 
an oxygen saturation monitor 58.
In  more  detailed  investigations,  several  serum values  are  used  to  obtain  a 
number of time points to generate a rate-constant, indicating the rate at which the dye 
disappears from the serum. In this fashion, it has been determined that, rather than 
being a true index of parenchymal function, there is a substantial influence of hepatic 
blood flow—both total hepatic blood flow and unit-by-unit flow within the hepatic 
parenchyma—on  the  retention  of  the  dye57.  Hepatic  artery  vasodilatation  may 
markedly influence the value in the same patient,  even on the same day. There is 
general  agreement  on  the  retention  values  that  support  major  liver  resection. 
Clearance is considered to be impaired when 15% or more of the dye remains within 
the plasma 15 minutes following the injection of 0.5 mg/kg ICG. Thus, patients with 
CP scores of 5 or 6 (Child A) and ICG 15 of greater than 14% are the “bad risk” CP A 
patients  whose  functional  reserve  is  limited.  ICG 15 correlates  strongly  with  CP 
scores.  It  also  correlates  strongly  with  the  rate  of  disappearance  of  tagged 
asialoglycoproteins59.
In two important papers assessing the technique of portal vein embolization-
improving hepatic functional reserve, Wakabayashi et al and Nakano et al correlated 
ICG  values  with  hepatic  hypertrophy  of  the  contralateral  lobe  after  portal  vein 
embolization60,  61.  The  ICG  disappearance  rate  generally  worsened  (in  16  of  19 
patients) at 2 weeks following treatment. Wakabayashi et al noted that ICG retention 
was prolonged in a number of patients who subsequently died,  but that numerous 
patients  underwent  resection  without  mortality,  even  in  the  face  of  elevated  or 
prolonged ICG clearance. Interestingly, the ICG retention rate worsened in virtually 
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all patients following portal vein embolization at 2 weeks, increasing from a mean of 
15.9±6.27% to 20.8±5.6% at 2 weeks. Either 2 weeks is too early to see improved 
ICG  return  to  baseline  clearance,  or  the  altered  blood  flow  due  to  portal  vein 
embolization results  in ICG 15 retention values that  do not permit an estimate of 
hepatocyte  function.  There  is  only  weak  evidence  that  this  test  can  be  useful  in 
assessing the successful accomplishment of liver resection, and lack of correlation is 
well  described60,62.  Furthermore,  the  variability  of  the  results  depending  on  total 
hepatic blood flow, and regional variations can markedly alter  the retention value. 
This reconfirms the information, available as early as 1989, that no quantitative liver 
function test provided a clear advantage beyond the CP score for predicting outcome 
in cirrhosis63.  There have always been strong correlations of the tests with the CP 
score, but none, including ICG retention, has been directly correlated with outcome.
99m-Tc-galactosyl-human serum albumin scintigraphy
Nuclear  imaging  with  a  variety  of  agents  has  existed  for  years,  including 
sulfur and gold colloid scans, and uptake and excretion of Rose Bengal and HIDA. 
These  scanning  agents  assessed  the  reticuloendothelial  uptake  of  colloid  and  the 
biliary excretion of HIDA. A more recent functional imaging technique with great 
promise involves receptor targeting with radiolabeled synthetic asialoglycoproteins. 
In 1966, an active transport  process involving the endocytotic removal of senescent 
serum  glycoproteins,  which  were  desialated  to  allow  them  to  be  identified  and 
removed from the circulation by the hepatic parenchyma, was described by Ashwell64. 
Taking advantage of the role of the liver in metabolizing senescent proteins through 
an active transport process facilitated by hepatocyte membrane receptors, the potential 
for using this  is a liver scanning agent was proposed by Eckelman et al65 ,  and a 
synthetic asialoglycoprotein, galactosyl-neoglycoalbumin (NGA), was complexed to 
99m-Tc  to  study  hepatocyte  binding  via  the  asialoglycoprotein  receptor  66-68.  In 
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addition, imaging provided volumetric/anatomic information, as well as a functional 
assessment of the ability of the liver to clear the synthetic asialoglycoproteins. Kudo 
et  al,  in  1991, reported the development  of a  similar  synthetic  asialoglycoprotein, 
galactosyl human serum albumin (GSA)69. This has subsequently been approved for 
use  as  a  liver-scanning agent  in  Japan (Nihon Mediphysics,  Nishinomiya,  Japan), 
although its use in the United States remains investigational.
Patients undergoing a GSA study receive a bolus injection of 185 MBq 99m-
Tc-GSA. A dynamic scintigraph is obtained with gamma cameras located over the 
heart and liver. The data can then be acquired as planar and single photon emission 
computed  tomographic  images.  In  an  effort  to  simplify interpretation  of  the  data, 
particularly with regard to proposed surgical use, most investigators have chosen to 
use the L15 value as an overall estimate of hepatocyte asialoglycoprotein receptor 
number. Thus the data can be acquired to indicate both the rate of uptake into the liver 
(or disappearance from the blood pool) and the total number of receptors available. 
For estimates of postoperative receptor volume, either SPECT images from the GSA 
scintigraph or CT estimates of the estimated remaining volume of a resection could be 
used to predict the total number of receptors remaining. The first summary of the US 
clinical  experience  with  the  asialoglycoprotein  analog,  NGA,  demonstrated  the 
correlation of NGA with the CP score, the aminopyrine breath test, and ICG retention 
67. Whether the test provided specific, unique, adjunctive information was not certain. 
Verification of these data followed with the Japanese analog, GSA, correlating this not 
only with the ICG retention at 15 minutes, but also with the index of cirrhosis scores, 
whereas the ICG retention had no correlation with the histologic scores indicating 
extent of necrosis and fibrosis in patients with chronic active hepatitis70.
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A follow-up article  by Kwon et  al  used technetium GSA to correlate  ICG 
retention and GSA functional imaging69,71.  This suggested that there is an absolute 
receptor number below which extended liver resection could not be performed. In 
their series of 90 patients, however, there were only two operative deaths, one in a 
low-risk group, and one a patient with marked discrepancy between the GSA and the 
ICG. In a  patient  with chronic hepatitis  such a  discrepancy may be important,  as 
patients who have the ability to regenerate may also have active, aggressive cirrhosis 
that may compromise the results.
Ha-Kawa et al provided further studies to define the spectrum of typical time-
activity curves for cirrhosis72. Their multicenter study indicated that this technology 
was  reproducible  in  a  number  of  settings.  Using  SPECT  images,  Hwang  et  al 
demonstrated that GSA could be used to predict the remainder of functional receptors, 
based  on  the  likely  size  of  the  resection  and  extent  of  receptor  populations 
remaining73.
In a natural history study of hilar cholangiocarcinoma, Akaki et al recognized 
that  occlusion  of  the  portal  vein  resulted  in  decreased  receptor  numbers  in  the 
occluded segment48.  Of  more relevance to  surgeons is  whether  this  resulted in an 
increase of receptors in the contralateral lobe. This was more directly addressed by 
Nakano et al, identifying patients for transarterial chemoembolization on the basis of 
receptor  numbers.  They  discovered  that  patients,  who  on  the  basis  of  their  low 
receptor  numbers  at  the  L15 point  of  the  GSA kinetic  scan,  received  portal  vein 
embolization  that  activity  was  found  to  increase,  suggesting  increased  receptor 
numbers for the entire liver after the resection. This information is confusing, because 
one would anticipate an ultimate homeostatic redistribution of receptors. Their data 
also  disclosed  that  a  number  of  patients  who  were  felt  to  be  clearly  resection 
candidates, and who then underwent transarterial chemoembolization, had decreases 
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in the receptor number61. The trend of ICG retention and GSA scanning suggested an 
increase in receptor numbers when in fact we expect homeostasis at best, but on an 
uncertain timetable. One simple conclusion is that blood flow may alter GSA results, 
much as ICG retention test values are altered by changes in hepatic blood flow such 
as occurs in  this  acute situation following portal  vein occlusion.  A more complex 
analysis raises the question as to whether the mathematical model yielding receptor 
numbers is related to hepatocyte mass. If so, receptor expression might still vary, for 
reasons  independent  of  the  known  hyperplasia  occurring  after  portal  vein 
embolization74. Similar derangements in GSA uptake also occur postoperatively. How 
this affects the time-activity curves results for GSA has been demonstrated by Tanaka 
et al[28]. But beyond the fact that changes occur, data regarding the specific changes 
resulting from specific surgical procedures are being acquired.
Kokudo et  al helped elaborate on this point by demonstrating that receptor 
recovery after hepatic resection occurred over a number of days, and that by 21 days 
after  resection  most  patients  still  demonstrated  marked  reduction  in  receptor 
concentrations76. Followed over time, receptor numbers appear to increase, even after 
150 days postresection. Thus estimation of reserve must take into account the fact that 
there will be a temporary dysfunction in asialoglycoprotein endocytosis (and hepatic 
blood  flow)  that  may improve  with  time,  as  long as  regeneration  occurs  without 
progressive fibrosis or complicating necrosis. Changes in blood flow as estimated by 
dynamic curves or alternative tests have not been done in the postoperative state.
Fujioka et al, attempting to estimate functional reserve and correlate this with 
CT images and ICG retention, used the L15 receptor number to identify those patients 
with likely complications. Only 1 patient in their group of 35 patients died from liver 
failure  77.  Thus  the  predictive  value  to  the  test  is  limited  by concomitant  careful 
selection.
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Uetake et al studied 13 patients and found that the 15-minute receptor volume 
correlated  with  an  estimate  of  the  resection  volume78.  This  led  to  an  accurate 
assessment of the postoperative receptor numbers, and they predicted the potential 
utility of GSA in the selection of patients for specific surgical procedures, based on 
estimates  of  functional  remnant  receptor  volume78.  Elaborating  on  this  finding, 
Wakabayashi et  al demonstrated that the receptor numbers could be estimated and 
correlated with CT volumetry79. And they demonstrated that, as with ICG, blood flow 
appeared  to  markedly  change  these  values,  raising  the  question  whether  simple 
receptor assay at 15 minutes (the L15) adequately conveys the extent of liver disease 
or recovery. In the most encouraging study to date, Kubo et al, employing portal vein 
embolization to increase hepatic reserve,  demonstrated a shift in receptor numbers 
from right to left lobe as the liver became hyperplastic on the left80. This is one of the 
truly encouraging findings from the early literature regarding GSA.
Overall, use of GSA clinically is in its infancy. That GSA results correlate with 
ICG,  CP,  and  other  indices  of  liver  function  is  not  disputed.  Whether  it  supplies 
additional information is a more complicated question to answer. It is clear from the 
foregoing discussion that GSA may suffer from some of the same drawbacks as ICG 
with regard to blood flow influences on the uptake of the agent. Virtually all of the 
studies discussed above correlate the GSA with another function test or the CP score. 
Not only are the results not correlated with outcomes, but also, the surgical results are 
uniformly excellent, and the small number of deaths does not provide an opportunity 
to correlate the test with the spectrum of postoperative liver dysfunction and failure. 
In addition, the simplified analyses using L15 alone may be an even greater problem 
for  GSA analysis  than  for  ICG,  having  to  take  into  account  not  only  functional 
hepatocyte mass but also blood flow which is impaired in cirrhosis.
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The search for a simple number such as the L15 from the GSA scan, or the 15-
minute ICG retention, ignores much important information acquired with these tests, 
and  may  do  an  unjust  disservice  to  both  of  these  methods.  A simple  means  to 
summarize the acquired information and yet reflect the extent of the data acquired 
would be invaluable.
One of  the most  intriguing aspects of portal  vein embolization to  improve 
hepatic  resection  options  in  cirrhosis  has  gone  beyond  the  demonstration  of  a 
volumetric change in the contralateral lobe after portal vein embolization, with and 
without  combined  hepatic  artery  embolization;  in  a  limited  study,  improved  ICG 
clearance  has  also  been  demonstrated70.  It  is  exciting  that  predictable  volume 
increases due to hyperplasia of contralateral unembolized liver parenchyma have now 
been followed by data convincingly demonstrating a degree of improved function—
even in cirrhotics. Kubo et al's data are the most convincing evidence to date that 
functional  improvement,  not  just  hyperplasia,  may  result  from  portal  vein 
embolization, and that Tc-GSA can detect this80.
As discussed above, function studies so far have been linked to CP scores, 
whereas the tests should more appropriately be linked to outcomes. The potential role 
of these agents in evaluating resection must demonstrate that they are improvements 
over CP stratification, or at least additive, and do not simply duplicate predictive data 
acquired from the CP score.
Patient selection and resection outcomes: lessons learned from four recent series
Torzilli  et  al,  in  1999,  reported  that  “no  mortality”  liver  resection  for 
hepatocellular  carcinoma  was  possible81.  For  preoperative  selection,  the  three 
parameters that they chose to employ were: (1) the presence of ascites, (2) the serum 
bilirubin  level,  and  (3)  the  ICG  15.  The  projected  remaining  liver  volume  was 
analyzed by computer  tomographic volume averaging.  For  patients with projected 
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remnant  volumes  under  40%  or  ICG  15  values  of  10%  to  20%,  portal  venous 
embolization was performed to increase the projected remnant volume preoperatively. 
One hundred seven patients underwent resection of hepatocellular carcinoma without 
mortality. The authors outlined a method of combining bilirubin and ascites to select 
patients  for  ICG retention studies  and to  suggest  which  patients  were appropriate 
candidates for limited resections or for extended resections.
Analysis of their selection criteria indicate that only CP score 5 or 6 (CP Class 
A) patients underwent surgery. ICG 15 was used to select the very best patients (ICG 
15 <10%) for extended resection (four or greater segments). All other CP Class A 
stratum patients underwent lesser resections as guided by the ICG 15 value. This is a 
notable series, with a remarkable reliance on ICG 15 for guidance and an aggressive 
use of portal vein embolization to attempt to increase functional reserve.
Poon et al, reporting their experience with 45 extended resections for HCC, 
selected CP Class A patients, who then underwent ICG 15 evaluation82. A combination 
of  detailed  imaging to  assess  remnant  volume and  laparoscopy with  laparoscopic 
ultrasound,  in  order  to  detect  moderate  to  severe cirrhosis  at  the  time of  planned 
resection, was employed to further select patients who might then undergo extended 
resection. Their group of 45 extended resection patients (greater than four segments) 
were compared with a group of 161 patients with four or fewer segment resections. In 
each group, a single death (out of three and six total  in each group, respectively) 
occurred that could be attributed to liver failure. Two of the deaths occurred in Child-
Pugh Class A patients and one occurred among 3 Child Class B patients. The authors 
concluded that extended resection was not indicated in Childs Class B patients. For 
CP Class A patients, a combination of the 15-minute ICG retention <14% for any 
patient, or a value between 14% and 20%, for a patient with a predicted large liver 
remnant volume, satisfactory results could be anticipated.
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Jarnagin et al reported their experience (1991–2001) with 1803 liver resection 
cases  for  primary  and  metastatic  disease83.  Preoperative  selection  of  CP Class  A 
patients was coupled with a detailed radiologic workup. A meticulous intraoperative 
assessment led to a mortality of 3.1%, with only 6 of 55 deaths being linked directly 
to  hepatic  failure.  The  authors  relied  heavily  on  parenchyma-sparing,  segmental 
resection. That the number of patients in the series developing liver failure was 5% 
(99  patients)  is  a  testimony to  the  aggressiveness  of  the  therapy.  Other  than  the 
projected number of hepatic segments involved and the perioperative blood loss, no 
other factors reliably predicted mortality.
Redaelli et al used galactose elimination capacity with the aminopyrine breath 
test, in an analogous manner to the use of ICG reported above, to select 167 patients 
who underwent curative resection; 6 patients of 167 or 3.6% died84. Only 2 died of 
acute liver failure, and these died despite undergoing tissue-preserving resections.
The  overwhelming  message  is  that  there  is  a  considerable  amount  of 
experience-based selection in each of these series. The avoidance of greater than four-
segment  resections  in  “bad-risk”  Child-Pugh  Class  A patients  is  a  clear-cut  goal, 
unless the option of portal vein occlusion is to be pursued. The estimated remnant 
volume—determined by preoperative imaging or by direct intraoperative assessment
—and  the  severity  of  the  cirrhosis  determined  at  surgery,  which  is  difficult  to 
precisely  quantify,  appear  to  be  of  critical  importance  in  patient  selection.  One 
question  that  arises  from these  papers  is  whether  there  is  a  test  that  provides  a 
substantial benefit in the selection of patients for resection beyond clinical experience 
and the CP score. The Memorial-Sloan Kettering data reported by Jarnagin suggest 
that experience may play a critical, positive role in patient selection if ICG retention is 
not used.
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Portal  vein  embolisation  (PVE)  is  gaining  increasing  acceptance  in 
preoperative treatment of selective patients before major liver resections. Induction of 
selective hypertrophy of nondiseased portion of the liver with PVE in patients either 
primary  or  secondary  hepatobiliary  malignancy  and  a  small  estimated  functional 
residual volume may result fewer complications and shorter hospital stay following 
resection. Additionally, PVE performed in patients initially considered unsuitable for 
resection  due  to  lack  of  sufficient  normal  parenchyma  may  add  to  the  pool  of 
candidates suitable for resection. 
Many attempts have been made over the past few decades to classify patients 
with liver disease to determine their prognosis following hepatic surgery. These have 
included the well-known and widely used Child-Turcotte-Pugh score (CTP) as well as 
more obscure methods such as indocyanine green clearance. Most recently, the Model 
for  End-Stage  Liver  Disease  (MELD)  score  has  gained  widespread  acceptance 
because of its use in prioritizing candidates for liver transplant. With the exception of 
measures  of  hepatic  function,  these  scoring  systems  are  all  mathematical 
computations involving various  laboratory values and clinical  assessments  and,  as 
such,  are  reflections  of  different  facets  of  pathology  and  physiology,  and  yield 
different degrees of reliability in different patient populations.
The MELD score was originally developed to predict short-term survival in 
patients  undergoing  transcutaneous  intrahepatic  portosystemic  shunt  procedures 
(TIPS),  and has been shown to be reliable  and predictive in  this  setting.97-100 It  is 
useful  in  assessing  prognosis  in  patients  with  alcoholic  hepatitis,  although  its 
superiority to CTP scores is not universally established. Furthermore, it has replaced 
the traditional CTP score in stratifying patients with end-stage liver disease awaiting 
transplantation  according to  guidelines  adopted  by the  United  Network for  Organ 
Sharing in 2002.101 Interestingly, MELD seems to predict patient and graft survival in 
cadaveric liver transplantation but not in living donor liver transplantation. 
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Extrapolating scoring schema from the originally described population is  a 
common practice.  However,  we practice  in  an  era  of  healthcare  resource  scarcity 
coupled with increasingly sophisticated surgical technique and critical and anesthetic 
care. More and more, we are in need of accurate and reliable methods for allocating 
scarce resources, as well as educating patients in making informed choices concerning 
their care. Use of MELD in patients undergoing elective liver resection is becoming 
more common but has not been validated. 
Given the shortcomings of currently used scoring systems, there is a constant 
effort  underway to  create  innovative,  accurate,  and  clinically  relevant  assessment 
tools.  However,  the  enthusiasm that  accompanies  any new system can lead  to  its 
application  to  situations  for  which  it  was  not  designed.  MELD scores  have  been 
shown  useful  in  stratifying  patients  with  end-stage  liver  disease  awaiting 
transplantation.  By allocating  organs  to  those  with  the  highest  scores  rather  than 
waiting time combined with subjective clinical assessment, improvements have been 
realized  in  short-term graft  and patient  survival.  However,  generalization  to  other 
types of hepatobiliary surgery does not seem warranted. In one analysis, ASA and 
CTP  were  both  superior  to  MELD  in  predicting  poor  postoperative  outcome. 
Interestingly,  both  CTP and ASA classification  schemes  involve  intuitive,  bedside 
assessment. This is especially true of the ASA classification, given its lack of explicit, 
defining criteria. The anesthesiologist assigning the score does so by the most general 
of  guidelines  with  no  specific  laboratory  values  or  mathematical  calculations 
whatsoever. There does seem to be a role for clinical judgment and experience in 
predicting which patients will do well and which will not.
The most significant difference between patients undergoing TIPS procedures 
or  awaiting  liver  transplantation  and  these  patients  undergoing  elective  hepatic 
resection is the variable rate of severe liver disease among the 2 groups. Presumably, 
all those in the first group already have severe liver dysfunction, although the exact 
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pathogenesis does differ. The incidence of hepatic dysfunction in the second group is 
much lower. Although primary hepatocellular carcinoma does most often develop in 
the setting of cirrhosis, 91% of the patients in this series had minimal or completely 
no evidence of liver disease. It is true that clinical signs and symptoms of liver disease 
are often absent until liver disease is quite advanced. However, the clinical differences 
between the 2 groups are significant. This may account for the different degrees of 
success with which MELD is able to predict postoperative mortality and morbidity.
Complications after Liver resection:
Pleural  effusion,  ascites,  wound  and  chest  infections,  subphrenic  abscess, 
biliary fistulas,  and hepatic insufficiency are frequent complications recorded after 
liver  resection.  Although  an  accurate  selection  of  patient  eligible  to  resection, 
advances  in  surgical  techniques,  and  perioperative  management  have  greatly 
contributed to lower the rate of perioperative deaths, stress must be put on reducing 
the postoperative complication rates reported to be still as high as 50%.As recently 
reported in the literature, there is a relationship between postoperative mortality and 
the  presence  of  cirrhosis  with  a  higher  mortality  rate  both  in  alcohol  abuse  and 
patients  affected  by  viral  hepatitis  B.  Postoperative  hepatic  failure  or  temporary 
impairment liver function are the most serious complications which can occur after 
liver  resection,  in  particular  in  cirrhotic  liver:  as  claimed  by  the  literature, 
postoperative hepatic failure, which is mainly preceded by insufficient remnant liver 
function,  massive  intraoperative bleeding followed by massive transfusion,  and or 
postoperative septic complication, is the major cause of hospital mortality. The debate 
about the extension of liver resection for HCC on cirrhosis is already open and it 
ranges from the widest resection to obtain radical result to the limited procedure to not 
make the liver function worse. Recent studies revealed that a liver remnant volume 
lesser than 25% is associated with an increased incidence of postoperative hepatic 
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dysfunction  in  patients  with  normal  liver,  but  liver  resection  on  cirrhosis  must 
conserve about 50% of total liver volume to preserve liver function. As it has been 
recently reported  in  a  series  of  Child–Pugh B and C,  an  estimated  liver  remnant 
volume (ELRV) lesser than 50% is associated with high mortality in the first year and 
no survival after the third year compared with an ELRV>50%. The preoperative liver 
remnant volume estimation led us to plan the surgical procedure in such a way as to 
both obtain a radical result and not make the liver function worse. This result is shown 
by the reduction of temporary impairment of liver function rates reported116. 
Improvements in surgical management including the use of modern devices, 
such as ultrasonic dissector, reduction in blood loss and blood transfusion, intermittent 
warm  ischemia,  maintenance  of  a  low  central  venous  pressure  during  hepatic 
transection,  and  shortening  the  procedure  length  have  made  considerable 
contributions  to  safer  procedure  and  improved  outcomes,  specially  in  lowering 
postoperative complication. 
Parenchymal transection is the most important stage of liver resection. The 
majority of intraoperative complications that affect patient outcome occur during this 
procedure. Many efforts have focused on achieving safe liver transection by designing 
the proper transection plane and developing techniques that enable performance of 
liver  parenchymal  splitting  in  a  bloodless  surgical  field.  Proper  transection  plane 
means that malignancies will be resected with adequate tumor-free margins and also 
that vascular and biliary structures, vital for the survival of the remaining liver and of 
the  patient,  will  be  protected  from  inadvertent  injuries.  Surgical  experience  and 
intraoperative  ultrasonographic  mapping  of  the  liver  allow  accurate  and  reliable 
determination  of  the  transection  plane.  In  most  series,  all  surgical  procedures  are 
performed after intraoperative ultrasonography which was used to define the precise 
extension of disease, the size of lesion, and the relationship with biliary and vascular 
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structure. Intraoperative ultrasonography helps the surgeon to make a realistic plan of 
transection and guides a careful anatomical transection. Bloodless liver splitting still 
remains the target of various methods, and many of them incorporate some type of 
vascular  exclusion,  exploiting  the  liver  capability  to  withstand  continuous  and 
intermittent warm ischemia up to 90 and 120 min, respectively. Various techniques, in 
addition  to  the  old  finger-fracture  method,  have  been  employed,  including  clamp 
crushing, ultrasonic dissection, hydrodissection, stapling with vascular endostaplers, 
heat coagulation, and sharp transection with a scalpel. The clamp crushing technique 
is the most popular because of its simplicity and effectiveness in controlling blood 
loss. This technique has been employed with or without liver vascular control. Sharp 
transection is used rarely; it warrants complete vascular control of the liver with either 
total  hepatic  vascular  exclusion  or  selective  hepatic  vascular  exclusion. 
Radiofrequency  ablation,  saline-link  and  radiofrequency  dissecting  sealer,  and 
LigaSure  have  been  introduced  in  recent  years  for  bloodless  liver  transection. 
Intraoperative bleeding is always one of the key problems in liver surgery. It has been 
demonstrated  that  massive  hemorrhage  during  partial  hepatectomy  contributes  to 
morbidity and mortality. Besides, subsequent blood transfusion facilitates recurrence 
of hepatic malignancies, including both primary and secondary tumors, and decreases 
survival of patients. Thus, control of intraoperative hemorrhage appeared to be very 
important in hepatic resection. Since Pringle first reported temporary normothermic 
occlusion of hepatic inflow by clamping the porta hepatis in the early 20th century, 
the  technique  named  Pringle  maneuver  has  been  used  worldwide.  But  clamping-
caused  hepatic  ischemia/reperfusion  injury  has  been  increasingly  recognized  with 
controversy on intermittent or continuous clamping in hepatic surgery. Comparison of 
experimental data showed that the two maneuvers lead to similar liver injury (even 
lightened injury in continuous clamping) in a short period, but intermittent clamping 
reduces hepatocellular damage in a long period of ischemia. It was demonstrated that 
oxygen-derived free radical played a crucial role in liver ischemia/reperfusion injury 
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as a main mechanism of hepatic injury after clamping.Some authors have reported 
that liver damage due to occlusion of hepatic inflow for 40 min was reversible in rats 
and humans, respectively. Moreover, no significant differences were found in values 
between the intermittent clamping and continuous and morphological findings also 
suggested analogous degree of injury. 
In a recent study authors have adopted Pringle maneuver during only 36.6% of 
liver  resections  and  they  chose  an  intermittent  clamping  that  lasted  for  20 min, 
interrupted by a restore break of 5 min, because as the liver damage due to occlusion 
of  hepatic  inflow  is  showed,  there  is  no  agreement  on  the  well-timed  length  of 
occlusion when it is required. They achieved a lower incidence of intraoperative and 
postoperative  bleeding  with  the  introduction  of  Ligasure® dissector;  hemostasis 
performed using Argon Beam associated with Ligasure® dissector leads them to carry 
out the surgical procedure whether with low bleeding or bloodless and they reduced 
the  length  of  both  Pringle  maneuver  and  surgical  procedure.  As  a  frequent 
complication after hepatectomy, pleural effusion mostly affects the right liver lobe 
with  an  incidence  rate  of  62.9%  for  hilar  cholangiocarcinoma  and  32.01%  for 
hepatocellular carcinoma151 - 155. 
During  hepatectomy,  conventional  mobilization  of  the  liver  involves 
mechanical  division  of  its  ligamentous  attachments  and  hemostasis  with  suture 
ligation, which usually results in damage to the integrity of lymphatic circumfluence. 
Compared with left  hepatectomy,  right  hepatectomy entails  extended division that 
causes  more  damage  to  the  lymphatic  path,  thereby  more  postoperative  pleural 
effusion occurs. Thus, to reduce the incidence of postoperative pleural effusion, it is 
necessary to control the division before hepatectomy. Long-term of hepatic occlusion 
leads to postoperative hepatic dysfunction and swelling of hepatic cell, which affects 
the lymphatic circumfluence. This plays a role in the development of postoperative 
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pleural effusion. The association of the length of hepatic occlusion with postoperative 
pleural effusion represents injury of hepatic cell and dimension of hepatectomy. It is 
important  to  shorten  the  time  of  hepatic  occlusion  in  an  attempt  to  decrease  the 
incidence of postoperative pleural effusion. When moderate or more ascites develops 
postoperatively, the elevated intraabdominal pressure expels the ascites into the thorax 
through the damaged diaphragm and adds to pleural effusion. 
The  incidence  of  biliary  leakage  in  liver  resection  without  biliary 
reconstruction was around 4–12%. The difference in the incidence of bile leakage in 
patients with or without liver cirrhosis is reported as not significant. Preoperative and 
operative factors were associated with the development of biliary complications: age, 
preoperative  white  blood  cell  count,  left-sided  hepatectomy,  high-risk  procedure, 
operation time, and intraoperative blood loss.Left-sided hemihepatectomy and central 
bisegmentectomy have a high incidence of postoperative bile leakage, as claimed in 
the literature; major hepatectomy is recorded as an independent risk factor for the 
development of postoperative bile leakage. It has previously been reported that the 
intraoperative bile leakage test  cannot exclude the possibility of postoperative bile 
leakage because damage to the bile ducts of a small segregated segment of the liver 
may continue to cause bile leakage without communication with the main biliary tree. 
Had it occurred, the amount of bile leakage from the bile ducts of a small segregated 
segment  of  the  liver  would  be  small,  and  the  site  of  bile  leakage  would  close 
spontaneously  in  the  short  term.  The  relatively  high  incidence  of  uncontrollable 
leakage in patients after  right-sided hepatectomy might  be related to the pumping 
action of the right hemidiaphragm. The results of nonoperative management of bile 
leakage after liver transplantation and other hepatobiliary procedures are encouraging, 
and nonsurgical measures have become the preferred approach. The presence of bile, 
blood, and devitalized tissue in the dead space after hepatic resection provides the 
ideal environment for bacterial growth. The combination of a sudden reduction in the 
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liver  volume  and  development  of  intraperitoneal  sepsis  frequently results  in  liver 
failure,  which  has  a  bad  prognosis.  As  a  lower  incidence  of  intraoperative  and 
postoperative  bleeding was  achieved with  the  introduction  of  Ligasure® dissector, 
same result was recorded on the ground of biliary leakage: this could be explained by 
both a better procedure planning and a bloodless surgical procedure; the reduction of 
length of Pringle maneuver could help in lowering the tissue damage that support 
biliary  leakage.  Wedge  resection  resulted  to  be  involved  in  biliary  leakage 
development (p=0.001) probably because the lesser the procedure is anatomical the 
more is the probability to damage the biliary tree. In the last few years, many centres 
have chosen anatomical  surgical  procedure like segmentectomy rather  than wedge 
resection  because  they  believe  that  an  anatomical  resection  could  reduce  the 
possibility  of  damage  of  vascular  and  biliary  system.  Most  important  factors, 
associated with arising of postoperative complications, result to be linked to surgical 
procedure:  the extension of resection,  the length of  clamping,  blood loss,  and the 
amount of transfusion; when a complication has arisen, a vicious circle is established 
where a complication breeds and holds up other complications. A learning curve exist 
and the experience of the surgeons who performs surgical procedures plays an equal 
role  as  the  innovation  in  surgical  devices,  advances  in  surgical  techniques,  and 
improving in preintra- and postoperative management. On the ground of experience 
from  various  centers,  the  following  recommendations  were  made:  every  liver 
resection  should  be  planned  after  intraoperative  ultrasonography  that  helps  the 
surgeon to make a realistic plan of transection; anatomical surgical procedure like 
segmentectomy should be preferred instead of wedge resection for it can prevent both 
vascular and biliary damage; modern devices should be used, like Argon Beam and 
Ligasure® dissector, to reduce the incidence of both intraoperative and postoperative 
bleeding and biliary leakage116. 
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Hospital Volume and Hepatectomy
The  empirical  relationship  between  high  hospital  volume  and improved 
outcomes  is  well  established  for  several  high-risk surgical  procedures.  Patients 
undergoing surgery at low-volume hospitals had a 3-fold increased risk of in-hospital 
mortality  after  adjusting  for differences  in  patient  characteristics.  In  addition,  we 
demonstrated that patients who have surgery at low-volume hospitals are at risk for 
several  specific  postoperative  complications.  These include  life-threatening 
complications,  such  as  acute  renal failure,  pulmonary  failure,  reintubation,  and 
nosocomial  pneumonia. After  entering  these  complications  into  the  multivariate 
model, hospital  volume was  no  longer  statistically  significant,  suggesting  that  the 
mechanism  of  improved  outcome  at  high-volume  hospitals may  be  fewer 
postoperative complications117. 
Several  population-based  studies  have  demonstrated  improved outcomes  for 
patients who undergo hepatic resection at high-volume vs low-volume centers. Begg et 
al120 merged data from the Surveillance, Epidemiology, and End Results database with 
clinical data for Medicare patients and studied the effect of volume on outcomes for 
several  high-risk  surgical  oncology  procedures.  This  study showed  a  significant 
reduction  in  30-day  mortality  associated with  high-volume  hospitals  after  hepatic 
resection for malignancy (5.4% at low-volume vs 1.7% at high-volume centers). Two 
studies using state discharge databases from Maryland and California also demonstrated 
decreased mortality at high-volume centers. Choti et al119 reviewed 606 liver resections 
done in Maryland between 1990 and 1996. High-volume hospitals in Maryland had an 
in-hospital mortality rate of 1.5% vs 7.9% at low-volume hospitals (P<.001). Using the 
discharge database in California, Glasgow et al studied the influence of hospital volume 
on outcomes of hepatic resection for hepatocellular carcinoma. For 507 patients, risk-
adjusted operative mortality was 22.7% at low-volume centers and 9.4% at high-volume 
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centers  (P =.002).  The  latter  study from  California  was  exclusively  investigating 
hepatocellular carcinoma, which represents a higher-risk patient population due to the 
frequency of underlying liver disease and the large extent of resection necessary to 
obtain negative margins. The relationship of hospital experience to both clinical and 
economic  outcomes  is  well  known.  Well-designed  studies  have shown  significant 
volume-outcome  effects  for  several  high-risk surgical  procedures,  including 
hepatectomy,  esophagectomy,  pancreaticoduodenectomy, abdominal  aortic  aneurysm 
repair,  coronary  artery  bypass  grafting, and  many  others118-120.  The  health  policy 
implications of this  volume-outcome relationship are important.  Many policymakers 
have suggested regionalizing complex surgery to high-volume centers of excellence, 
and some health policy initiatives are currently underway. Currently, the best surrogate 
for quality of care at different hospitals is hospital experience. To concentrate patient 
care in the hands of high-quality (high-volume) hospitals, the Leapfrog group has set 
minimum volume standards that institutions must meet to provide those services to 
their  patients.  Birkmeyer  and colleagues121  estimated that almost 2600 deaths after 
surgery could be avoided in the United States each year by "universal adoption" of 
this evidence-based hospital referral policy. 
Regionalization,  however,  may not be an acceptable solution for all  patient 
populations. Some patients may prefer to undergo surgery at local institutions, even if 
confronted  with  a  higher risk  of  perioperative  mortality.  In  rural  areas,  referring 
patients to  higher-volume centers  may be physically or financially unfeasible.  The 
estimate by Birkmeyer et al121 of the benefits of regionalization included only urban 
areas.  Good  outcomes can  be  achieved  in  these  select  low-volume  centers.  For 
example, a recent series of 18 liver resections (4 trisegmentectomies, 4 lobectomies, 4 
segmentectomies,  and  6  wedge  resections)  in a  community  hospital  in  Maryland 
reported a 0% mortality rate. This experience may be anecdotal but it suggests that 
hospital volume may not be the best surrogate for quality. Further studies  are needed 
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to  elucidate  the factors that  explain the volume-outcome relationship. The hospital 
volume  variable  is  complex  and  likely  represents several  structure  and  process 
differences between high- and low-volume hospitals. Isolating these differences will 
allow for changes at low-volume hospitals that will improve outcome.  Some evidence 
exists  that demonstrates the importance of intensive care unit (ICU) physician and 
nurse staffing in predicting outcomes after complex surgery. Having daily rounds by 
an ICU physician was associated with a 4-fold reduction in mortality and a decreased 
risk of complications after hepatic resection in one recent study, and has also been 
demonstrated  for  other  high-risk  surgical procedures.  In  addition,  having  "more 
nurses" (1 ICU nurse to 1 or 2 patients) in the ICU at night was associated with  fewer 
pulmonary  complications  and  less  resource  use  after  hepatic resection.  These 
differences in ICU structure may contribute to differences in complications between 
high- and low-volume centers, which can be changed to improve outcomes at lower-
volume centers. 122 -127 
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PATIENTS AND METHODS
During a period from August, 2004, to March, 2007, 40 consecutive patients 
underwent elective hepatic resection for benign or malignant hepatobiliary diseases at 
the Department of Surgical Gastroenterology, Government Stanley Hospital, Chennai, 
Tamilnadu.  The  hepatectomies  were  performed  by a  surgical  team specialized  in 
hepatobiliary surgery.
Preoperative Assessment
All  patients  had  ultrasonography and  contrast  computed  tomography  (CT) 
scan  or  magnetic  resonance  imaging  to  evaluate  the  liver  or  biliary  pathology. 
Assessment of liver function was based on Child’s classification, liver biochemistry, 
and  coagulation  profile.  In  patients  with  hepatocellular  carcinoma  (HCC), 
preoperative biopsy is not routinely performed if the lesion is operable. CT volumetry 
was used to aid assessment of liver function reserve.
Operative Techniques
Patients undergoing hepatectomy were generally explored through a bilateral 
subcostal incision with vertical midline extension. In selected patients with a large 
right lobe tumor or a small tumor located at the superior and posterior part of the right 
liver, a thoracoabdominal approach was used.22 Staging laparoscopy have been used 
with increasing frequency to assess the extent of tumors and to assess the severity of 
any cirrhosis and size of liver remnant.23 After laparotomy, intraoperative ultrasound 
was routinely performed to detect any lesions in the contralateral lobe, any tumor 
invasion of portal vein or hepatic veins, and to define the relationship between the 
tumor and major intrahepatic vessels. Parenchymal transection was performed using 
the  finger-fracture technique,  Kelly Clyssis,  ultrasonic  dissector  (CUSA).  In some 
cases of right hepatectomy for a large tumor that made mobilization of the right lobe 
difficult, parenchymal transection was performed without premobilization of the liver 
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and extra hepatic control of the right hepatic vein (anterior approach).24 The hepatic 
duct was isolated and ligated or sutured at the time of hepatic transection. We have 
routinely mobilized the liver and isolated the portal structures and hepatic veins extra 
hepatically or hepatic veins were isolated during hepatic transection on the left side. 
Intermittent Pringle maneuver was not used routinely, with increased experience in 
recent  years,  Pringle  maneuver  was  used  only  when  significant  bleeding  was 
encountered.  Instead,  more  attention  was  paid  to  lowering  of  the  central  venous 
pressure to  below 5 cm H2O to reduce  venous bleeding during transection.  Total 
vascular exclusion was not performed in any patients. Meticulous attention was paid 
to the preservation of function in the remnant liver by avoiding prolonged rotation, 
hypoxic  injury,  or  venous  congestion  due  to  overloading  of  circulation.  After 
transection, bile leakage test was performed using normal saline injection via a cystic 
duct cannula, and any leakage site was carefully repaired with fine sutures. Blood 
transfusion was initiated when the hemoglobin level fell to below 8 g/dL or when 
there was a  hemodynamic instability.  We use fresh frozen plasma during or  after 
operation. An abdominal drain was placed almost routinely after hepatic resection. 
Postoperative Care
All patients with major hepatic resection were monitored in the intensive care 
unit in the immediate postoperative period. The need for postoperative mechanical 
ventilation  was  determined  by  the  anesthetists.  Pain  control  was  provided  by 
intravenous  pentazocine  injection  if  the  patient  needed  mechanical  ventilation; 
otherwise, pain was controlled by on demand epidural analgesia through an epidural 
catheter placed preoperatively. A broad-spectrum antibiotic was given for at least 5 
days,  and  intravenous  albumin  was  given  for  cirrhotic  patients  with 
hypoalbuminemia. Oral feeding was started when the bowel sounds returned. 
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Data Collection and definitions
To analyze the trends in perioperative variables and outcome of hepatectomy 
in our institution over the 3 -year study period, Pre-, intra-, and postoperative data 
were  recorded  prospectively  in  a  computerized  database.  Histopathological  data 
including status of underlying liver (normal,  chronic hepatitis,  cirrhosis) were also 
collected. The types of hepatic resection were described according to the terminology 
recommended  by  the  International  Hepato-Pancreato-Biliary  Association.25 
Concomitant  procedure  was  defined  as  any  extrahepatic  organ  resection,  portal 
lymphadenectomy, or extrahepatic biliary resection and reconstruction. Thoracotomy 
and  cholecystectomy  were  not  considered  as  additional  extrahepatic  procedures. 
Hospital mortality was defined as any death that occurred during the same hospital 
admission for the hepatic resection. 
Statistical Analysis
Continuous variables were expressed as median and interquartile range and 
compared using Mann-Whitney  U test. Categorical variables were compared by the 
_2 test  with Yates’ correction or  Fisher  exact  test  where appropriate.  Multivariate 
analyses of risk factors of morbidity and mortality were performed using a binary 
logistic  regression  model.  All  statistical  analyses  were  performed  using  statistical 
software (SPSS 9.05 for Windows, SPSS, Inc, Chicago, IL). Results were considered 
significant at P < 0.05.
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RESULTS
During the study period, 23 men and 17 women underwent hepatectomy for 
benign or malignant hepatobiliary diseases  (Table 1). The most common indication 
was HCC, which accounted for 72% of all hepatectomies. Two patients underwent 
hepatectomy  for  metastatic  disease  1  colorectal  and  1  noncolorectal  (renal  cell 
carcinoma).The most common benign indication was for hemangioma. One patient 
underwent major hepatectomy for persistent bronchobiliary fistula and 1 for a rare 
benign fibrous tumour of the liver.
Preoperative Variables
Age, gender, presence of comorbid illness, presence of cirrhosis, presence of 
thrombocytopenia (platelet value < 150 X 109/ L), hypoalbuminemia (Serum albumin 
< 40 gms/L),  hyperbilirubinemia (S.bilirubin > 2mgm/L),  prothrombin time (> 12 
seconds), elevated serum creatinine (>1.3 mgm %) were the preoperative variables 
that were considered.  Table 2 shows the preoperative variables.  The mean age of 
patients who underwent hepatectomy was 47.1 years [41.83 – 52.32]; the median age 
was 49 years [14 – 82 years]. There were 23 males and 17 females. 37.5% of patients 
had  comorbid  medical  conditions.  The  most  common  comorbid  condition  was 
cardiovascular disease,  followed by diabetes mellitus,  chronic respiratory disease , 
and  chronic  renal  disease.  11  out  of  40  patients  were  cirrhotics  (27.5%)  and  the 
remaining had normal  liver.  36/40 patients  had  Serum albumin < 40gms%,  mean 
prothrombin time was 16.2 seconds [11 – 37 seconds], thrombocytopenia was seen in 
31/40 patients. Elevated serum creatinine was seen in only 5% of patients. 
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Operative Variables
Of the 40 patients, 31 (77%) underwent major hepatic resection, whereas the 
other 9 patients (13%) underwent minor hepatic resection of 2 or fewer segments. 
Table  3 depicts  the  frequencies  of  various  types  of  hepatectomy.  Most  of  the 
hepatectomies  were  anatomic  resections,  with  only  5%  being  non  anatomical 
resections.  Extended  right  or  classical  right  hepatectomy  was  performed  in  a 
substantial  proportion  of  patients.  Concomitant  extra  hepatic  procedures  were 
performed in 13 patients (32.5%). These procedures included partial excision of the 
diaphragm (n _ 4), hepatico jejunostomy with
Table 1
Indications of Liver resection
Malignant disease 34(85%)
I Primary liver malignancy 
1. Hepatocellular carcinoma 29(72%)
2. Intrahepatic cholangiocarcinoma  1(2.5%)
II Metastatic liver malignancy 
3. Colorectal  1(2.5%)
4. Others  1(2.5%)
III Extrahepatic Cholangiocarcinoma
5. Cholangiocarcinoma  2(5 %)
Benign disease 6(15%)
I Hemangioma 2(5%)
II Adenoma 1(2.5%)
III Persistent Bronchobiliary fistula 1(2.5%)
IV Benign fibrous tumour 1(2.5%)
V Others  1(2.5%)
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Table2
Pre operative variables
Age (Median) 49 (14 - 82) years
Gender (M:F) 23:17
Presence of comorbid illness 15(37.5%)
Cirrhotic liver  11(27.5%)
Thrombocytopenia (Plt < 150 X 109) 31(77.5%)
Hypoalbuminemia (S.albumin < 40gms/L) 36(90%)
Hyperbilirubinemia (S.Bilirubin >2mgm/dl) 5(12.5%)
Prothrombin time (> 12 seconds) 16.2(11 - 37)
Elevated Serum creatinine (> 1.3 mgm/dl) 2(5%)
or without excision of the bile duct (n _ 4), adrenal gland (n _ 8), lung (n _ 1), Some 
patients had more than 1 extrahepatic procedure. Additional ablation of liver tumors 
in  the  contralateral  lobe  was  performed  in  2  patients,  including  radiofrequency 
ablation  in  2 patients  in  group II.  Table 4 shows operative  variables.  The use of 
Pringle  maneuver  was  in  45% of  patients.  The  abdominal  drainage  was  used  in 
majority of patients (95%). Average operative blood loss was 342 (50 – 2000) ml. 
Perioperative blood transfusion was needed in 18/40(45%) patients. Average volume 
of blood transfusion required was 1.47 (0 - 6) units. Volume of fresh frozen plasma 
transfusion required was 5.55(0 – 18) units. 
Perioperative Outcome
The overall morbidity and hospital mortality of the 40 patients were 40% (n _ 
16)  and  5  %  (n  _  2),  respectively.  The  causes  of  death  were  hemorrhage  with 
uncontrolled coagulopathy in 1 patient and hepatic failure in 1 patient. The hospital 
mortality  rate  was  higher  after  hepatic  resection  for  malignant  disease  than  after 
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hepatic resection for benign disease (5.8% versus 0%), and the hospital mortality rate 
in cirrhotic patients was equal to noncirrhotic patients. When stratified according to 
the  type  of  hepatectomy,  the  hospital  mortality  was  observed  in  1  patient  with 
extended  right  hepatectomy  and  1  patient  with  extended  left  hepatectomy.  The 
hospital mortality rates of segmentectomy and nonanatomical resection was 0% while 
that of major resections was 2/31(11%).  Table 5 shows the perioperative outcomes. 
The mean ICU stay was 3.3 (1 – 14) days; post operative mechanical ventilation was 
needed in 12/40(30%) of patients. Post operative day of resumption of enteral feeds 
was 4.3(0-10) days. The mean hospital stay was 16.2 (10 – 40) days. Morbidity was 
observed in  16/40 patients  and the  various  complications  and their  frequency are 
listed in Table 6.
Table 3
Types of hepatic resections
Major resections 31(89%)
Rt Hepatectomy 16(40%)
Rt Extended Hepatectomy 6(15%)
Lt Hepatectomy 6(15%)
Lt Extended Hepatectomy 2(5%)
Central Hepatectomy 1(2.5%)
Minor resections 9(11%)
Bisegmentectomy
Lt lateral sectionectomy 5(12.5%)
Rt Posterior sectorectomy  1(2.5%)
Other resection involving 2 segments 1(2.5%)
Unisegmentectomy 0
Non anatomical resection 2(5%)
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Table 4
List of Operative variables
Extent of Hepatic resection
Major 31(77.5%)
Minor  9(22.5%)
Concomitant extra hepatic procedure 13(32.5%)
Use of Pringle’s Maneuver 18(45%)
Use of abdominal drain 38(95%)
Operative Blood loss, ml 342.5(50 - 2000) 
Perioperative blood transfusion 18(45%)
Intra operative hypotension 13(32.5%)
Volume of Blood transfusion, units 1.47(0 - 6)
Volume of Fresh frozen plasma, units 5.55(0 - 18)
Table 5
Perioperative Outcomes
ICU care unit stay, days 3.3(1 – 14)
Post operative mechanical ventilation 12(30%)
Post operative parenteral nutrition  8(20%)
Post operative day of resumption of oral feeding, days 4.3(1-10 days)
Hospital stay, days 16.2(10 – 40)
Overall morbidity 16(40%)
Hospital mortality  2(5%) 
Among the surgical  complications,  wound infection and wound dehiscence 
were the most common complications observed and contributed to morbidity.  Bile 
leak was observed in 3/40 (7.5%) of patients. Transient ascites, liver failure, pleural 
effusions were the medical complications  that were noted at  a  frequency of 30%, 
7.5% and 7.5% respectively.
Three patients had liver failure which was managed medically and of the three 
two patients survived and one died. 
Table 6
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Complications
Surgical Complications no(%)
Bile collection 3(7.5%)
Intraabdominal abscess 1(2.5%)
Post operative hemorrhage 1(2.5%)
Wound infection 6(15%)
Wound dehiscence 3(7.5%)
Medical Complications
Liver failure 3(7.5%)
Ascites 12(30%)
Variceal bleeding 0
Broncho pneumonia 1(2.5%)
Pleural effusion 3(7.5%)
Renal failure 1(2.5%)
RISK FACTORS FOR MORBIDITY AND HOSPITAL MORTALITY
Univariate analyses
Table  7 shows  the  influence  of  preoperative  and  operative  variables  on 
morbidity  and  hospital  mortality  of  the  40  patients  by  univariate  analysis. 
Concomitant  comorbid  illness,  hyperbilirubinemia,  hypoalbuminemia,  prolonged 
prothrombin  time,  major  hepatic  resection,  concomitant  extra  hepatic  procedure, 
Pringles  maneuver,  blood  loss  of  more  than1  L,  need  for  perioperative  blood 
transfusion and fresh frozen plasma more than six units and presence of intraoperative 
hypotension were associated with increased morbidity, whereas presence of comorbid 
illness,  prolonged  prothrombin  time,  concomitant  extra  hepatic  procedures  and 
operative  blood  loss  of  more  than  1  litre,  was  associated  with  increased  hospital 
mortality. 
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Multivariate analyses
Multivariate  analyses  of  risk  factors  for  morbidity  and  hospital  mortality, 
respectively,  were  performed  by  entering  the  significant  factors  identified  in 
univariate  analyses into a logistic  regression model.  None of the patients  attained 
statistical significance as independent factors for predicting morbidity and mortality 
(Table 8).
Table 7
Risk factors predicting morbidity and mortality – Univariate analyses
Morbidity %  P Value       Mortality %       P value
Gender  
Male (n= 23)                          13 (56)      0.18 2 (8)              0.21
Female (n= 17)       6 (35)             0 
Age   
     <   70years (n=37)                   17(45)     0.48              2(5)                  0.68
     >   70 Years (n= 3)                   2(66)  0 
Co morbid Illness 
     No (n= 25)                    6(24)     0.00              0                     0.05
     Yes (n= 15)                   13(86)  2(13)
Diagnosis 
      Benign (n= 6)       1(16)   0.12  0                   0.58
      Malignant (n= 34)                  18(52)    2(5)
Cirrhotic liver  
No(29)                  13(44)  0.58  1(3)               0.47
Yes(11)                   6(54)  1(9)
48
Hyper bilirubinemia
No(29)                       9(31) 0.007  1(3)              0.46
Yes(11)                      10(90)  1(9)
Hypo albuminemia
       No (n= 28)     8(28)            0.00                  1(3)             0.52
      Yes (n= 12)        11(91)  1(9)
Prothrombin time > 12s
       No (n= 28)       11(39)            0.00                  0                     0.02
      Yes (n= 12)       8(66)              2(16)
Thrombocytopenia
       No (n=9)  3(33)    0.33                 0             0.43
      Yes (n=31)      16(51)                          2(6)
S. Creatinine (> 1.3 mg/L)
        No (n= 38)    17(44)              0.12                 2(5)                0.73
       Yes   (n= 2)     2(100)   0
Extent by Resection
Major (n= 31)           18(58)        0.01           2(6)            0.43 
Minor (n= 9)            1(11)  0
Extra hepatic procedure
No (n=27)            8(29)            0.001            0               0.04
Yes (n=13)           11(84)  2(15)
Pringle maneuver
No (n= 21) 5(23)          0.001           0               0.11
Yes (n= 19)            14(73)     2(10)
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Bl. Loss
< 1 litre (n= 26) 7(26)        0.001  0                0.05
> 1 litre (n= 14) 12(85) 2(14)
Blood transfusion
No (n= 22)             4(18)          0.001            0                0.11
Yes (n= 18)             15(83)      2(11)
Fresh frozen plasma ( > 6 units)     
No (n= 23)             6(26)         0.002              0                0.09
Yes (n= 17)             13(76)            2(11)
Intra op Hypotension
     No (n= 27)             8(29)          0.001               0                0.58
Yes (n= 13)             11(84)         2(15)
Table 8
Risk factors predicting morbidity and mortality – Multivariate analyses
Parameter  Significance Risk Ratio
(95% confidence interval)
Extra hepatic resection 0.03  12.5  (1.20 – 12.9) 
Pringles Maneuver 0.54  2.05 (0.20 – 20.9)  
Blood Loss 0.69  0.37 (0.01 – 54)  
Blood Transfusion 0.07  14.9 (0.78 – 285)  
FFP Transfusion 0.56  2.1 (0.16 – 28)  
Intra op Hypotension 0.87  0.87 (0.01 - 17)  
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DISCUSSION
Liver resections are increasingly performed as a standard treatment of various 
hepatobiliary  diseases.  However,  there  were  few  contemporary  studies  of  the 
perioperative outcome of hepatic resection.3-5 In a study of 747 hepatectomies Belghiti 
et al3 demonstrated a operative mortality of 1% in patients with normal liver, but the 
operative mortality rate was 8.7% in cirrhotic patients. Jarnagin et al4 reported a series 
of 1803 patients with hepatic resection and demonstrated a significant improvement in 
the perioperative outcome over the study period, which was attributed to the increased 
use of parenchymal preserving segmental resections and decrease in the number of 
hepatic segments resected. More recently Imamura et al reported zero mortality after 
hepatic resection in a series of 915 patients. The authors emphasized the importance 
of case selection, and they adopted a strict selection in terms of liver function reserve. 
The  current  study  demonstrated  that  improved  perioperative  outcome  could  be 
achieved even when the indications of hepatectomy were extended to More high-risk 
patients with borderline liver function reserve, advanced age ,and comorbid medical 
illnesses. 
Our patient population was characterized by a high proportion of patients with 
HCC.
In  contrast,  in  the  study  of  Jarnagin  et  al,  metastatic  colorectal  cancer 
accounted for 62% of the indications for hepatectomy, whereas cirrhosis or fibrosis 
was  present  in  only  8.8%  of  the  patients.  Hepatic  resection  in  cirrhotic  liver  is 
technically more challenging than resection in normal liver, with increased risk of 
bleeding, septic complications, and postoperative liver failure. Several authors have 
emphasized the importance of strict  selection in terms of liver function reserve in 
ensuring favorable perioperative 5,11,31Outcomes in patients with chronic liver disease. 
ICG clearance is a commonly used test of liver function to aid selection of patients for 
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hepatectomy.  In the study by5 Imamura et  al,  only patients  with ICGR-15 of  less 
than10% were offered right hepatectomy or extended hepatectomy. The use of such a 
strict selection criterion was considered by the authors to be a major factor for the 
excellent  result  of  zero  mortality  in  their  series.  Poon  et  al  has  offered  major 
hepatectomy to patients with less favorable liver function reserve. Before 1997, major 
hepatic resection was offered to patients with ICGR-15 of less than 14%. In recent 
years, they have adopted an even more liberal selection criterion and offered right 
hepatectomy or extended hepatectomy to patients with22ICGR-15 up to 20%. Their 
aggressive approach was partly driven by the improving survival  results  that  they 
have observed in hepatic resection for HCC, even for large HCC that  22,32  required 
extended hepatectomy. Excluding living donors with normal liver undergoing donor 
hepatectomy for liver transplantation, the proportion of patients with resection of 2 Or 
more Couinaud segments were 80. 2% in their series, as5 Compared with 27.3% in the 
study by Imamura et al. In fact, the proportion of major hepatic resection was not the 
highest in this series compared with the other 3 large series3-5 of hepatectomy recently 
reported in the literature. 
While  major  hepatic  resection  was  a  risk factor  for  hospital  mortality,  the 
hospital mortality of 5% after major hepatic resection is acceptable. Cirrhosis was not 
associated with increased morbidity and hospital mortality in both univariate analyses 
and multivariate analyses. And, thrombocytopenia was not a significant risk factor in 
both univariate and multivariate analyses of both morbidity and hospital mortality, 
and hypo albuminemia was another risk factor for hospital mortality and morbidity in 
univariate analysis. Jarnagin et al also found that preoperative thrombocytopenia was 
an independent risk factor of mortality after hepatic resection, and hypo albuminemia 
was a risk factor for morbidity. In the study by Poon et al , majority of patients had 
higher  hypo  albuminemia  and  thrombocytopenia,  yet  the  operative  morbidity  and 
hospital  mortality  had  decreased.  Presumably  the  adverse  effects  of  hypo 
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albuminemia  and  thrombocytopenia  were  compensated  by  the  improvement  in 
surgical techniques and perioperative care.
While our experience is more concentrated on hepatic resection for HCC, a 
more  aggressive  surgical  approach  has  also  been  extended  to  other  hepatobiliary 
cancers. Recent studies from other groups have demonstrated improved survival with 
aggressive surgical approach in other hepatobiliary malignancies such as colorectal 
liver metastasis  and hilar  cholangiocarcinoma.33–35 Resection of these malignancies 
often  requires  concomitant  extrahepatic  procedures  such  as  synchronous  colonic 
resection  or  extrahepatic  biliary  resection  and  reconstruction.  Extrahepatic  biliary 
procedures are  also required for some benign indications such as hepatolithiasis.36 
While  previous  studies  found  that  extrahepatic  procedures  increased  the  risk  of 
mortality  in  patients  undergoing  hepatectomy,3,4 in  our  experience,  extrahepatic 
procedures  were associated  with increased morbidity and increased  mortality.  The 
capability  to  perform  hepatectomy  combined  with  major  extrahepatic  procedures 
safely  should  help  to  expand  the  role  of  hepatic  resection  to  more  complicated 
hepatobiliary  diseases.  Two  strategies  have  further  expanded  the  indications  for 
hepatic resection. One is preoperative portal vein embolization to induce hypertrophy 
of liver remnant in patients with inadequate liver function reserve and small  liver 
remnant volume. This strategy can be employed not only in patients with normal liver 
but  also in selected patients with chronic liver  disease or biliary obstruction from 
extrahepatic biliary malignancies.35,37 The other strategy is the use of radiofrequency 
ablation in combination with hepatic resection, which can be used to treat multiple 
bilobar malignancies when it is anatomically not feasible or too risky to encompass all 
the lesions by hepatic resection alone.38
In addition to the liver function reserve, advanced age and comorbid illnesses 
are other pre-existing host conditions that sometimes preclude patients from hepatic 
resection. Some previous studies have reported that advanced age was a significant 
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risk  factor  for  morbidity  or  mortality  after  hepatic  resection,4,14,20,39 and  comorbid 
illnesses such as cardiovascular disease and diabetes mellitus have also been reported 
to be significant risk factors.11,39,40 However, recent studies from Hong Kong group 
and  others  have  demonstrated  that  advanced  age  or  comorbid  illnesses  may  not 
adversely affect the outcome of hepatic resection, provided that careful preoperative 
assessment and meticulous perioperative management were executed.41–43 Hence, in 
recent years,  we have become more liberal in offering hepatic resection to elderly 
patients and patients with comorbid illnesses. In this study, advanced age was not 
associated  with  significantly  increased  morbidity  or  mortality.  While  associated 
comorbid illness was associated with higher morbidity and mortality. Nevertheless, 
we would like to emphasize that careful preoperative case selection and meticulous 
postoperative management in liaison with the anesthetists and the relevant specialist 
physicians are essential to achieve favorable outcome in elderly patients and patients 
with comorbid illnesses. The operative morbidity and hospital mortality have been 
reduced in recent years the proportions of elderly patients and patients with comorbid 
illnesses,  in  particular  cardiovascular  disease,  have  increased  significantly.  Of  the 
medical complications, there is a significant reduction in the incidence of respiratory 
complications.  Better  postoperative  pain control  with the use of  patient-controlled 
analgesia  probably  has  played  an  important  role  in  reducing  respiratory 
complications. With the aging population worldwide, the survival benefit of hepatic 
resection for malignant diseases in elderly patients is expected to increase, and hence 
hepatic  resection  is  going to  play an  increasingly important  role  in  this  group of 
patients. A previous study on HCC by Hong Kong group showed a similar survival 
benefit from hepatic resection in elderly patients compared with younger patients.41 
While we advocate that the role of hepatectomy can be expanded in elderly patients 
and patients  with  comorbid  illnesses  such as  diabetes  mellitus  and cardiovascular 
diseases that are under control, we caution against hepatic resection in patients with 
impaired renal function, because elevated serum creatinine level was a significant risk 
factor of mortality in many studies though it was not an observation in our study. A 
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previous  study  on  extended  hepatic  resection  has  also  identified  elevated  serum 
creatinine level as a risk factor of postoperative mortality.44
Jarnagin et al4 observed that the improved perioperative outcomes of hepatic 
resection in their study were largely the result of a decline in the number of liver 
segments resected. In contrast, in our study, the overall improvement in perioperative 
outcome over  the  study period  was  mainly ascribed to  the  reduced mortality  and 
morbidity in patients undergoing major hepatic resection. Over the study period, there 
have  been  substantial  changes  in  the  surgical  technique  of  hepatic  resection  and 
perioperative management. It is difficult to attribute the reduced operative morbidity 
and hospital mortality to a specific factor. Among the risk factors of morbidity and 
mortality in the Univariate analyses, perioperative blood transfusion was a risk factor 
for  morbidity  and  when  blood  transfusion  is  reduced  with  modern  techniques  of 
parenchymal  transection  the  peri  operative  outcomes  of  hepatectomy  can  be 
considerably  improved.  Several  changes  in  the  surgical  technique  over  the  years, 
including the use of ultrasonic dissection instead of the finger-fracture technique, the 
adoption of a low central venous pressure during hepatic transection and the use of a 
vascular stapler for control of hepatic veins, together with the increased experience of 
the surgeons, have all contributed to the reduction in operative blood loss. A notable 
change  in  the  surgical  technique  in  recent  years  is  the  reduced  use  of  Pringle 
maneuver. Although many authors have previously demonstrated in a randomized trial 
that  Pringle  maneuver  was  effective  in  reducing  blood  loss  during  hepatic 
transection,26 Fan et al has also observed a time constraint in the total duration of 
Pringle maneuver  that  the liver  could tolerate,45 which could sometimes lead to a 
hasty transection and hence more bleeding. With increased experience, we found that 
hepatic transection could be performed with low blood loss even without the Pringle 
maneuver. The absence of a time constraint from Pringle maneuver allows the surgeon 
to  control  each  bleeding  point  precisely  before  continuing  with  the  transection. 
Change  in  attitude  toward  the  use  of  Pringle  maneuver  is  partly  influenced  by 
growing experience in living donor hepatectomy, in which portal clamping is never 
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applied. In a study by Poon et al of the 163 living donor hepatectomies performed 
without Pringle maneuver in their unit including 129 patients with right lobe donation, 
only 1 patient  required perioperative blood transfusion,  and there was no hospital 
mortality. In recent years, most of the hepatic resections, including those on cirrhotic 
liver,  were performed without Pringle maneuver,  and operative blood loss and the 
requirement for blood transfusion were on the decreasing trend. Perioperative blood 
transfusion could increase perioperative morbidity and mortality by causing immune 
suppression, and it has also been shown to adversely affect the long-term survival 
after hepatic resection for HCC or colorectal metastasis46, 47. The achievement of zero 
blood transfusion rates should be a common goal of all surgeons performing hepatic 
resection.
In  our  study  by  univariate  analysis  concomitant  comorbid  illness, 
hyperbilirubinemia,  hypoalbuminemia,  prolonged  prothrombin  time,  major  hepatic 
resection, concomitant extra hepatic procedure, Pringles maneuver, blood loss of more 
than1 L, need for perioperative blood transfusion and fresh frozen plasma more than six 
units  and  presence  of  intraoperative  hypotension  were  associated  with  increased 
morbidity,  whereas  presence  of  comorbid  illness,  prolonged  prothrombin  time, 
concomitant extra hepatic procedures and operative blood loss of more than 1 litre, was 
associated  with  increased  hospital  mortality.  This  was  in  consistence  with  multiple 
studies from various centers. In multivariate analyses none of the parameters attained 
statistical significance as independent factors for predicting morbidity and mortality.
This is probably because the number of patients included in the study was 
small and for a good multivariate analysis the minimum number of patients required 
is at least 50. 
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CONCLUSION
This  study  demonstrated  that  perioperative  outcome  has  improved  despite 
extending the indication of hepatectomy to more high-risk patients. Hence, the role of 
hepatectomy in the management of benign and malignant hepatobiliary diseases can 
be expanded. 
Concomitant  comorbid  illness,  hyperbilirubinemia,  hypoalbuminemia, 
prolonged  prothrombin  time,  major  hepatic  resection,  concomitant  extra  hepatic 
procedure,  Pringles maneuver,  blood loss of more than1 L, need for perioperative 
blood  transfusion  and  fresh  frozen  plasma  more  than  six  units  and  presence  of 
intraoperative  hypotension  were  associated  with  increased  morbidity,  whereas 
presence of comorbid illness, prolonged prothrombin time, concomitant extra hepatic 
procedures  and  operative  blood  loss  of  more  than  1  litre,  was  associated  with 
increased hospital mortality.
Reduced perioperative blood loss hence reduction in transfusion requirement 
is a main contributory factor for the improved outcome, and further effort should be 
directed toward improving surgical techniques to achieve bloodless hepatic resection.
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